Bioinformatics and systems-biology approach to identify common pathogenic mechanisms for COVID-19 and systemic lupus erythematosus.

Yinlan WuYanhong LiYu ZhouXiufeng BaiYi Liu

Published in: Autoimmunity (2024)

COVID-19 and SLE patients share many common hub genes, related pathways and regulatory networks. Based on these common targets, we found many potential drugs that could be used in treating patient with COVID-19 or COVID-19 combined with SLE.

Keyphrases

coronavirus disease
systemic lupus erythematosus
sars cov
disease activity
end stage renal disease
respiratory syndrome coronavirus
chronic kidney disease
genome wide
peritoneal dialysis
climate change
bioinformatics analysis
risk assessment
network analysis
patient reported outcomes
patient reported